The mRNA export pathway licenses viral mimicry response and antitumor immunity by actively exporting nuclear retroelement transcripts
Science Translational Medicine · 09.04.2025 · 17 (793)
DOI: 10.1126/scitranslmed.ado4370 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 09.04.2025. Verfasst von Xiaoqiang Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), State Key Laboratory of Experimental Hematology, Key Laboratory of Im…. Hauptthemen laut MEDLINE: RNA, Messenger, Retroelements, Cell Nucleus, Molecular Mimicry. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 61 Literaturangaben.
Abstract (Originalsprache)
Nuclear retroelement transcripts (RTs), which can be elicited both transcriptionally and posttranscriptionally, form double-stranded RNA (dsRNA) in cytosol to trigger the viral mimicry response (VMR) and antitumor immunity. However, the strength of the induced VMR varies tremendously across tumor types, and the underlying mechanisms remain poorly understood. Here, we demonstrate that the mRNA export pathway modulates the VMR through actively exporting nuclear RTs for cytosolic dsRNA formation after their induction. Tumor cells hijack this process for immune evasion through aberrant coactivator-associated arginine methyltransferase 1 (CARM1) expression. Mechanistically, we show that the cytoplasmic transportation of RTs by the mRNA export pathway is counteracted by the RNA exosome, which cleaves multiple transcripts within this pathway, including those encoding the essential DExD-box helicase 39A (DDX39A) and the adaptor protein ALYREF. CARM1 enhances the RNA exosome activity to attenuate the nuclear export of RTs by the mRNA export pathway through two synergistic mechanisms: (i) transcriptionally activating several RNA exosome components and (ii) posttranslationally methylating arginine 6 of the RNA exosome subunit EXOSC1, which protects it from proteasome-mediated degradation. Collectively, our study highlights the critical active regulatory role of the mRNA export pathway in transporting nuclear RTs into the cytosol for triggering the VMR and tumor immunity. Furthermore, we propose that enhancing the mRNA export pathway activity, either through CARM1 inhibition or RNA exosome modulation, could reinforce the therapeutic agent-induced VMR, thus holding the promise for overcoming tumor immune evasion and immunotherapy resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), State Key Laboratory of Experimental Hematology, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Province an…
- Tianjin's Clinical Research Center for Cancer, Tianjin Key Laboratory of Digestive Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer…
- Clinical Research Center, Hainan Hospital, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou University of Chinese Medicine, Hainan, 570203, China.
ORCID-Profile: Xiaoqiang Wang, Jiaxing Jin, Han Yan, Jinhua Liu, Shan Huang, Mingrui Guo, Xinyue Cheng, Ting Deng, Yong Gu, Xin Gao, Deqing Hu
Zitieren
APA
Wang, X., Jin, J., Yan, H., Liu, J., Huang, S., Bai, H., Guo, M., Cheng, X., Deng, T., Ba, Y., Gu, Y., Gao, X., & Hu, D. (2025). The mRNA export pathway licenses viral mimicry response and antitumor immunity by actively exporting nuclear retroelement transcripts. Science Translational Medicine, 17(793). https://doi.org/10.1126/scitranslmed.ado4370
Vancouver
Wang X, Jin J, Yan H, Liu J, Huang S, Bai H, et al. The mRNA export pathway licenses viral mimicry response and antitumor immunity by actively exporting nuclear retroelement transcripts. Science Translational Medicine. 2025;17(793). doi:10.1126/scitranslmed.ado4370
BibTeX
@article{Wang2025,
author = {Wang, Xiaoqiang and Jin, Jiaxing and Yan, Han and Liu, Jinhua and Huang, Shan and Bai, Hui and Guo, Mingrui and Cheng, Xinyue and Deng, Ting and Ba, Yi and Gu, Yong and Gao, Xin and Hu, Deqing},
title = {The mRNA export pathway licenses viral mimicry response and antitumor immunity by actively exporting nuclear retroelement transcripts},
journal = {Science Translational Medicine},
year = {2025},
volume = {17},
number = {793},
doi = {10.1126/scitranslmed.ado4370}
}
EUVIMED